Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

ClinicalTrials.gov ID: NCT00002922

Public ClinicalTrials.gov record NCT00002922. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 2, 2026, 2:47 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Evaluation of Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with recurrent or metastatic head and neck cancer.

Study identification

NCT ID
NCT00002922
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 21, 1997 (Actual)
Primary completion
Sep 2001 (Actual)
Completion
Not listed
Last update posted
Jun 18, 2023

Started 1997

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
21
Facility City State ZIP Site status
Veterans Affairs Medical Center - Palo Alto Palo Alto California 94304 —
Stanford University Medical Center Stanford California 94305-5408 —
Sylvester Cancer Center, University of Miami Miami Florida 33136 —
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 —
Emory University Hospital - Atlanta Atlanta Georgia 30322 —
Veterans Affairs Medical Center - Atlanta (Decatur) Decatur Georgia 30033 —
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago Illinois 60611 —
Veterans Affairs Medical Center - Chicago (Lakeside) Chicago Illinois 60611 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61602 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
New England Medical Center Hospital Boston Massachusetts 02111 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131 —
Veterans Affairs Medical Center - East Orange East Orange New Jersey 07018-1095 —
University of Rochester Cancer Center Rochester New York 14642 —
CCOP - Merit Care Hospital Fargo North Dakota 58122 —
Ireland Cancer Center Cleveland Ohio 44106-5065 —
CCOP - Geisinger Clinical and Medical Center Danville Pennsylvania 17822-2001 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
CCOP - MainLine Health Wynnewood Pennsylvania 19096 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —
Veterans Affairs Medical Center - Milwaukee (Zablocki) Milwaukee Wisconsin 53295 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002922, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 18, 2023 · Synced Nov 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002922 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →